People with cognitive impairments have fewer gut microbes and less microbial diversity. That’s good news because we can ...

The revisions signal a shift toward looking at MS more as a biologically based disease, noted Xavier Montalban, MD, PhD, of ...

BOSTON, Sept. 23, 2024 (GLOBE NEWSWIRE) -- Cerevance, a company focused on developing precision novel therapeutics for central nervous system (CNS) diseases, announced that Craig Thompson, chief ...

“Our discovery of RORB for these selectively vulnerable cells gives us the opportunity to study in detail exactly why they ...

MSIG Insurance, a provider of general insurance solutions in Asia and part of the MS&AD Insurance Group, has introduced ...

SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, ...

A class of drugs used to treat diabetes has been linked to a 20% lower risk of dementia and Parkinson's disease. | ...

A new study by scientists at Nottingham Trent University will use non-invasive techniques to investigate the targeted ...

A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...

New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.

Our sense of smell is more than just a way to enjoy food or detect dangers like fire. It turns out that changes in the ...

A D.C.-area doctor calls a new study on people who pack in only one or two days of exercise a week “empowering.” ...